AMGN
Amgen Inc.
Stock
$407.27−14.24 (−3.38%)Close Oct 1, 2026
Cash flow statement
| Line | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $12.5B | $10.0B | $11.5B | $8.5B | $9.7B | $9.3B | $10.5B | $9.2B | $11.3B | $11.2B | $10.4B | $9.7B | $9.0B | $6.3B | $5.9B | $5.1B | $5.8B | $6.3B | $6.0B | $5.4B |
| Capital expenditures | $2.3B | $1.9B | $1.1B | $1.1B | $936M | $880M | $608M | $618M | $738M | $664M | $738M | $594M | $718M | $693M | $689M | $567M | $580M | $530M | $672M | $1.3B |
| Free cash flow | $10.2B | $8.1B | $10.4B | $7.4B | $8.8B | $8.4B | $9.9B | $8.5B | $10.6B | $10.5B | $9.6B | $9.1B | $8.2B | $5.6B | $5.2B | $4.6B | $5.2B | $5.8B | $5.3B | $4.1B |
| Stock-based compensation | $492M | $494M | $530M | $431M | $401M | $341M | $330M | $308M | $311M | $329M | $311M | $322M | $408M | $403M | $362M | $341M | $353M | $284M | $262M | $263M |
| Buybacks | — | $0 | $200M | $0 | $6.4B | $5.0B | $3.5B | $7.7B | $17.8B | $3.2B | $3.0B | $1.9B | $138M | $832M | $4.6B | $8.3B | $3.8B | $3.2B | $2.3B | $5.1B |
| Dividends paid | $5.3B | $5.1B | $4.8B | $4.6B | $4.2B | $4.0B | $3.8B | $3.5B | $3.5B | $3.4B | $3.0B | $2.4B | $1.9B | $1.4B | $1.1B | $500M | $0 | $0 | — | — |
| Dividends per share | $7.42 | $9.66 | $9.13 | $8.64 | $7.95 | $7.22 | $6.56 | $5.95 | $5.41 | $4.77 | $4.15 | — | — | — | — | — | — | — | — | — |
| Free cash flow margin | 26.7% | 22.0% | 31.1% | 26.1% | 33.4% | 32.3% | 38.9% | 36.5% | 44.5% | 46.0% | 41.8% | 42.2% | 41.0% | 30.0% | 30.1% | 29.2% | 34.6% | 39.7% | 35.4% | 28.0% |